Format

Send to

Choose Destination
Nutrients. 2018 Oct 1;10(10). pii: E1398. doi: 10.3390/nu10101398.

Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target.

Author information

1
Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain. mjaneiro@alumni.unav.es.
2
IdISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain. mjaneiro@alumni.unav.es.
3
Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain. mariaja@unav.es.
4
IdISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain. mariaja@unav.es.
5
Department of Nutrition, Food Science and Physiology, Centre for Nutrition Research, University of Navarra, 31008 Pamplona, Spain. fmilagro@unav.es.
6
CIBERobn, CIBER Fisiopatología de Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain. fmilagro@unav.es.
7
Department of Nutrition, Food Science and Physiology, Centre for Nutrition Research, University of Navarra, 31008 Pamplona, Spain. jalfmtz@unav.es.
8
CIBERobn, CIBER Fisiopatología de Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain. jalfmtz@unav.es.
9
IMDEA Food Institute, 28049 Madrid, Spain. jalfmtz@unav.es.
10
Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain. msolaszu@unav.es.
11
IdISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain. msolaszu@unav.es.

Abstract

Trimethylamine N-oxide (TMAO) is a molecule generated from choline, betaine, and carnitine via gut microbial metabolism. The plasma level of TMAO is determined by several factors including diet, gut microbial flora, drug administration and liver flavin monooxygenase activity. In humans, recent clinical studies evidence a positive correlation between elevated plasma levels of TMAO and an increased risk for major adverse cardiovascular events. A direct correlation between increased TMAO levels and neurological disorders has been also hypothesized. Several therapeutic strategies are being explored to reduce TMAO levels, including use of oral broad spectrum antibiotics, promoting the growth of bacteria that use TMAO as substrate and the development of target-specific molecules. Despite the accumulating evidence, it is questioned whether TMAO is the mediator of a bystander in the disease process. Thus, it is important to undertake studies to establish the role of TMAO in human health and disease. In this article, we reviewed dietary sources and metabolic pathways of TMAO, as well as screened the studies suggesting possible involvement of TMAO in the etiology of cardiovascular and neurological disorders, underlying the importance of TMAO mediating inflammatory processes. Finally, the potential utility of TMAO as therapeutic target is also analyzed.

KEYWORDS:

antibiotics; cardiovascular disease; gut dysbiosis; inflammation; microbiota; neurological disorder

PMID:
30275434
PMCID:
PMC6213249
DOI:
10.3390/nu10101398
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center